thymoquinone has been researched along with Triple Negative Breast Neoplasms in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (23.53) | 24.3611 |
| 2020's | 13 (76.47) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, J; Fu, J; Fu, S; Liu, X; Peng, J; Wang, Q; Wei, C; Xiao, T; Xie, X; Zou, H | 1 |
| Adinew, GM; Badisa, RB; Elhag, R; Mazzio, EA; Mochona, B; Soliman, KFA; Taka, E | 1 |
| A, P; B, SR; K, K; P, H; S, S; Sjs, B | 1 |
| Adinew, GM; Antonie, LM; Badisa, RB; Messeha, SS; Soliman, KFA; Taka, E | 1 |
| Adinew, G; Badisa, R; Messeha, SS; Soliman, KFA; Taka, E | 1 |
| Fu, J; Khan, MA; Li, J; Tania, M; Zheng, M | 1 |
| Adinew, GM; Badisa, RB; Messeha, SS; Soliman, KFA; Taka, E | 1 |
| Adinew, GM; Messeha, S; Mochona, B; Redda, KK; Soliman, KFA; Taka, E | 1 |
| Eissa, RA; El Tayebi, HM; Elgohary, S | 1 |
| Ahmad, FJ; Akhter, S; Garg, N; Kumar Jain, G; Selvapandiyan, A; Zafar, S | 1 |
| Adhikary, A; Ahir, M; Bhattacharjee, M; Bhattacharya, S; Chattopadhyay, S; Debnath, GH; Ghosh, A; Ghosh, S; Gupta, P; Maiti, S; Mukherjee, P | 1 |
| Çınar, V; Delibaşı, N; Gökçe, S; Güler, A; Hamurcu, Z; Nurdinov, N; Ozpolat, B; Ünal, TD | 1 |
| Chen, HC; Fu, J; Junaid, M; Khan, MA; Mei, Z; Tania, M; Zheng, M | 1 |
| Ahmad, FJ; Ahmad, J; Barkat, MA; Beg, S; Khan, MA | 1 |
| Bayraktar, R; Calin, GA; Kabil, N; Kahraman, N; Lopez-Berestein, G; Mokhlis, HA; Ozpolat, B | 1 |
| Greenshields, AL; Hoskin, DW; Sutton, KM | 1 |
| Aksu, H; Çakır, M; Canatan, H; İskender, B; İzgi, K; Kurt, B; Şakalar, Ç; Sezen, S; Turan, A | 1 |
2 review(s) available for thymoquinone and Triple Negative Breast Neoplasms
| Article | Year |
|---|---|
Therapeutic Potential of Thymoquinone in Triple-Negative Breast Cancer Prevention and Progression through the Modulation of the Tumor Microenvironment.
Topics: Antineoplastic Agents, Phytogenic; Benzoquinones; Female; Humans; Phytotherapy; Triple Negative Breast Neoplasms; Tumor Microenvironment | 2021 |
Insights into the Targeting Potential of Thymoquinone for Therapeutic Intervention Against Triple-negative Breast Cancer.
Topics: Antineoplastic Agents, Phytogenic; Benzoquinones; Clinical Trials as Topic; Female; Humans; Molecular Targeted Therapy; Nigella sativa; Seeds; Triple Negative Breast Neoplasms | 2018 |
15 other study(ies) available for thymoquinone and Triple Negative Breast Neoplasms
| Article | Year |
|---|---|
TQFL12, a novel synthetic derivative of TQ, inhibits triple-negative breast cancer metastasis and invasion through activating AMPK/ACC pathway.
Topics: Acetyl-CoA Carboxylase; AMP-Activated Protein Kinases; Animals; Antineoplastic Agents; Apoptosis; Benzoquinones; Cell Cycle; Cell Line, Tumor; Cell Movement; Disease Models, Animal; Drug Tapering; Humans; Mice; Models, Molecular; Protein Binding; Signal Transduction; Structure-Activity Relationship; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays | 2021 |
Modulation of gene expression by thymoquinone conjugated zinc oxide nanoparticles arrested cell cycle, DNA damage and increased apoptosis in triple negative breast cancer cell line MDA-MB-231.
Topics: Apoptosis; Benzoquinones; Cell Cycle; Cell Line, Tumor; DNA Damage; Gene Expression; Humans; Triple Negative Breast Neoplasms; Zinc Oxide | 2021 |
Thymoquinone Alterations of the Apoptotic Gene Expressions and Cell Cycle Arrest in Genetically Distinct Triple-Negative Breast Cancer Cells.
Topics: Benzoquinones; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Female; Gene Expression; Humans; TNF Receptor-Associated Factor 2; Triple Negative Breast Neoplasms | 2022 |
Thymoquinone Anticancer Effects Through the Upregulation of NRF2 and the Downregulation of PD-L1 in MDA-MB-231 Triple-Negative Breast Cancer Cells.
Topics: B7-H1 Antigen; Benzoquinones; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Humans; NF-E2-Related Factor 2; Triple Negative Breast Neoplasms; Up-Regulation | 2022 |
Thymoquinone upregulates IL17RD in controlling the growth and metastasis of triple negative breast cancer cells in vitro.
Topics: Benzoquinones; Cell Line, Tumor; Female; Humans; Neoplastic Processes; Receptors, Interleukin; Triple Negative Breast Neoplasms | 2022 |
Anticancer Effects of Thymoquinone through the Antioxidant Activity, Upregulation of Nrf2, and Downregulation of PD-L1 in Triple-Negative Breast Cancer Cells.
Topics: Antioxidants; B7-H1 Antigen; Down-Regulation; Glutathione; Humans; Hydrogen Peroxide; NF-E2-Related Factor 2; RNA, Messenger; Triple Negative Breast Neoplasms; Up-Regulation | 2022 |
Thymoquinone Inhibition of Chemokines in TNF-α-Induced Inflammatory and Metastatic Effects in Triple-Negative Breast Cancer Cells.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Chemokines; Humans; Triple Negative Breast Neoplasms; Tumor Microenvironment; Tumor Necrosis Factor-alpha | 2023 |
Thymoquinone, a Novel Multi-Strike Inhibitor of Pro-Tumorigenic Breast Cancer (BC) Markers: CALR, NLRP3 Pathway and sPD-L1 in PBMCs of HR+ and TNBC Patients.
Topics: Calreticulin; Carcinogenesis; Humans; Leukocytes, Mononuclear; NLR Family, Pyrin Domain-Containing 3 Protein; Triple Negative Breast Neoplasms | 2023 |
Co-encapsulation of docetaxel and thymoquinone in mPEG-DSPE-vitamin E TPGS-lipid nanocapsules for breast cancer therapy: Formulation optimization and implications on cellular and in vivo toxicity.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzoquinones; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Docetaxel; Drug Resistance, Neoplasm; Female; Humans; MCF-7 Cells; Mice; Mice, Inbred BALB C; Nanocapsules; Phosphatidylethanolamines; Polyethylene Glycols; Triple Negative Breast Neoplasms; Vitamin E | 2020 |
Delivery of thymoquinone through hyaluronic acid-decorated mixed Pluronic® nanoparticles to attenuate angiogenesis and metastasis of triple-negative breast cancer.
Topics: Animals; Benzoquinones; Cell Line, Tumor; Chick Embryo; Humans; Hyaluronic Acid; Mice; MicroRNAs; Nanoparticles; Poloxamer; Triple Negative Breast Neoplasms | 2020 |
Thymoquinone Inhibits Proliferation and Migration of MDA-MB-231 Triple Negative Breast Cancer Cells by Suppressing Autophagy, Beclin-1 and LC3.
Topics: Antineoplastic Agents; Autophagy; Beclin-1; Benzoquinones; Cell Movement; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Humans; Microtubule-Associated Proteins; Molecular Structure; Structure-Activity Relationship; Triple Negative Breast Neoplasms; Tumor Cells, Cultured | 2021 |
Synergistic Role of Thymoquinone on Anticancer Activity of 5-Fluorouracil in Triple Negative Breast Cancer Cells.
Topics: Apoptosis; Benzoquinones; Cell Line, Tumor; Cell Proliferation; Fluorouracil; Humans; Triple Negative Breast Neoplasms | 2022 |
Thymoquinone inhibits cell proliferation, migration, and invasion by regulating the elongation factor 2 kinase (eEF-2K) signaling axis in triple-negative breast cancer.
Topics: Animals; Benzoquinones; Cell Line, Tumor; Cell Movement; Cell Proliferation; Elongation Factor 2 Kinase; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Neoplasm Invasiveness; RNA, Messenger; Signal Transduction; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays | 2018 |
Thymoquinone, a bioactive component of black caraway seeds, causes G1 phase cell cycle arrest and apoptosis in triple-negative breast cancer cells with mutant p53.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Benzoquinones; Carum; Caspases; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Female; G1 Phase Cell Cycle Checkpoints; Genes, p53; Humans; Membrane Potential, Mitochondrial; Mutation; Seeds; Triple Negative Breast Neoplasms | 2014 |
The combination of thymoquinone and paclitaxel shows anti-tumor activity through the interplay with apoptosis network in triple-negative breast cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Benzoquinones; Carcinoma, Ehrlich Tumor; Cell Line, Tumor; Cell Movement; Cell Survival; Drug Screening Assays, Antitumor; Female; Gene Expression; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Mammary Neoplasms, Experimental; Mice, Inbred BALB C; Neoplasm Transplantation; Paclitaxel; Triple Negative Breast Neoplasms; Tumor Burden | 2016 |